Monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab) AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Here is the key information for the supplier, prepared according to the provided procurement documents:

Procurement object

  • What is being purchased: Monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab).
  • Lot division: The procurement is divided into 2 lots:
    • Lot 1: For the treatment of new patients (Cetuximab or Panitumumab).
    • Lot 2: For continued treatment of patients (Panitumumab only).
  • Specific features: The purchaser does…
     
    To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

c4t_10278954_1.xml

Pirkimo dokumentai/10. SS 7 priedas. NSRAD.docx

Pirkimo dokumentai/11. SS 9 priedas Pasiūlymo vertinimo kriterijai ir sąlygos.docx

Pirkimo dokumentai/12. SS 10 priedas. Pirkimo sutartis.docx

Pirkimo dokumentai/1. SS.docx

Pirkimo dokumentai/2. BS.docx

Pirkimo dokumentai/3. SS 1 priedas. Terminai.docx

Pirkimo dokumentai/4. SS 2 priedas. TS.docx

Pirkimo dokumentai/5. SS 8 priedas. Žalieji reikalavimai.docx

Pirkimo dokumentai/6. SS 3 priedas. Tiekėjų pašalinimo pagrindai.docx

Pirkimo dokumentai/7. SS 4 priedas. Tiekėjų kv reik. ir Reik. nac saugumui.docx

Pirkimo dokumentai/8. SS 6 priedas. Pasiūlymas.docx

Pirkimo dokumentai/9. SS 5 priedas. EBVPD/espd-request.pdf

Pirkimo dokumentai/9. SS 5 priedas. EBVPD/espd-request.xml

Pirkimo dokumentai/9. SS 5 priedas. EBVPD/README.txt

Pirkimo dokumentai.zip

Buyer contracts

Main information

Procurement number
10278954
Procurement type
Open competition
Deadline
Published date
Value
N/A
Procurement object type
N/A
Buyer
Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos
Description
Procurement categories
33652100 - Antineoplastic agents
33600000 - Pharmaceutical products
33652000 - Antineoplastic and immunomodulating agents

Other information

Procurement summary link
4909573, 1002/3350/4909573
Deadline for submission of tenders (days/hours)
N/A
Name of the contracting authority
Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos
Name
Monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab)
PV Procurement Unique ID
N/A
Proposal evaluation criteria (the selected evaluation criterion will apply to all procurement parts/categories)
Kaina/Sąnaudos
Description
The contracting authority intends to purchase monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab) (hereinafter – the medicinal product / item). The requirements for the procurement object are set out in Annex 2 to the Special Conditions "Technical Specification".
Procurement object type
Goods
Directive
2014/24/ES (Classic)
Procurement method
Open tender
Contract type (once a contract type is selected, it will apply to all procurement parts)
Purchase contract
CPV codes
33652100
Determination of the winner for each object
Yes
E. creation of auctions
No
NUTS codes
LT
Estimated value (EUR)
N/A
Above or below the international procurement value threshold
Above
Deadline for submission of tenders or requests to participate in procurement
Deadline for sending invitations
N/A
Deadline for submitting requests for clarifications
24/11/2026 14:00
Uploading documents with explanations
Yes
Date of familiarization with the proposals
Allow suppliers to express interest in the system
Yes
The procurement is divided into Part(s) (DPS - into categories)
Yes
Number of part(s)
2
Part(s) Name(1)
For the treatment of new patients - medicinal product Cetuximab or Panitumumab Determination of the winner for each item: No
Part(s) Name(2)
For continuous patient treatment - medicinal product Panitumumab Winner determination per item: No
Proposals for Part(s)
All Parts
Duration of the contract in months or years, excluding extensions
12 months
Validity period of the offer in days or months
90 days
EU funding
No
Alternative proposals are permitted
No
Date of publication and/or invitation
TED links to published notices

https://ted.europa.eu/udl?uri=TED:NOTICE:757088-2026:TEXT:LT:HTML

Date of determining the winner
N/A
Notice language
LT
Number of persons familiarizing themselves with the proposals
One

Ready to get started?

Subscribe and enjoy all the benefits every day!